About Us
WHO WE ARE
Our Mission
We are dedicated to advancing regenerative medicine through the research and development of high-quality iPS-derived exosomes. Our mission is to bring innovative therapeutic solutions from the laboratory to clinical application.
As a global company with operations in Japan, the US, UK, and India, we combine world-class scientific expertise with rigorous manufacturing standards to deliver products that meet international regulatory requirements.
Our work is built on the pioneering iPS cell technology developed at Kyoto University, and we remain committed to translating this groundbreaking science into real-world medical applications.
[Company Image]
Our Values
These core principles guide everything we do, from research to collaboration.
Scientific Rigor
Every claim we make is backed by peer-reviewed research and rigorous experimentation.
Patient Safety
Safety is paramount in all our research, from initial discovery through clinical application.
Ethical Responsibility
We adhere to the highest ethical standards in sourcing, research, and communication.
Transparency
We openly share our findings, including limitations, to advance the field responsibly.
Our Journey
Foundation
Established as a regenerative medicine venture originating from Kyoto University and the University of Tokyo.
iPS Cell Breakthrough
Culture medium used in Professor Yamanaka's world-first successful experiment to generate human iPS cells.
Global Expansion
Listed on JASDAQ and expanded operations globally with bases in Japan, the US, UK, and India.
Regenerative Medicine
Full-scale entry into regenerative medicine sector, advancing research and development of stem cell therapies.
iPS Exosome Leadership
Global leader in iPS-derived exosome research with products meeting international regulatory standards.
Global Presence
Japan
Headquarters
United States
Operations
United Kingdom
Operations
India
Operations
9,000+
Research Papers Cited
20+
Years of Experience
4
Global Locations
Partner With Us
Interested in collaboration or learning more about our work? We'd love to hear from you.
Contact Us